`BIB_059`

Patel SP, Othus M, Chen Y, et al. Neoadjuvant–Adjuvant or Adjuvant-Only Pembrolizumab in Advanced Melanoma. NEJM 2023;388(9):813–823. PMID 36856617. SWOG S1801. [Tasks: L, 17, 18] Tier: 2 Grade: A Retrieved: 2026-05-06

Evidence grade: A
Tier: 2
Cited by tasks: L, 17, 18
Identifiers: PMID:36856617

↗ Follow the original source for full context

Full extracted findings & patient-implication analysis: bibliography/BIB_059/findings.md (research corpus). This page is a short context summary — not individualised medical advice.